V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009007 | 280006227 | 1.76 | 72 | Palliative (P) | 2017-09-15 | 2017-09-15 | Vinorelbine (oral) | N | N | 280029599 | VINCRISTINE |
| 280009008 | 280006229 | 1.78 | 69.8 | Palliative (P) | 2015-09-12 | 2015-10-07 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 02 | N | 280029609 | IVADO |
| 280009009 | 280006229 | 1.56 | null | Palliative (P) | 2015-09-19 | 2015-09-27 | Carbo F | null | null | 280029609 | IVADO |
| 280009010 | 280006230 | 1.6 | 15.7 | Palliative (P) | 2013-05-26 | 2013-06-01 | TRASTUZUMAB | N | N | 280029620 | CREATE TRIAL |
| 280009011 | 280006231 | 0.62 | 60 | Palliative (P) | 2015-10-09 | 2015-10-10 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 280029620 | CTD |
| 280009012 | 280006232 | 1.65 | 100.8 | Disease modification (D) | 2017-04-12 | 2017-04-20 | BCG Intravesical | 2 | N | 280029627 | DACTINOMYCIN + VINCRISTINE |
| 280009013 | 280006233 | 1.74 | 78.3 | Palliative (P) | 2015-03-14 | 2015-03-14 | Bendamustine+Rituximab (1st Course) | Y | N | 280029628 | VIDE |
| 280009014 | 280009263 | 1.77 | 93 | Palliative (P) | 2016-03-27 | 2016-04-03 | METHOTREXATE | N | N | 280029628 | GEMCITABINE + NAB-PACLITAXEL |
| 280009015 | 280009264 | 1.7 | 74.4 | Curative (C) | 2013-11-15 | 2013-11-25 | KESTREL Trial | 2 | N | 280029636 | CARBOPLATIN + LIPOSOMAL DOX |
| 280009016 | 280006235 | null | 57.25 | Palliative (P) | 2018-02-25 | 2018-03-11 | Capecitabine (14 days)+Carboplatin | 02 | N | 280029639 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009017 | 280009265 | 1.78 | null | null | null | 2018-01-11 | Capecitabine + Streptozocin | 2 | N | 280029639 | VIDE |
| 280009018 | 280009266 | 1.7 | 82.7 | Palliative (P) | 2017-02-25 | 2017-02-25 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 280029642 | CARBO + FLUOROURACIL |
| 280009019 | 280006238 | 1.85 | 82.7 | Curative (C) | 2017-03-13 | 2017-03-17 | LIPOSOMAL DOXORUBICIN | N | N | 280029654 | MELPHALAN |
| 280009020 | 280006238 | 1.65 | 40.2 | Palliative (P) | 2018-02-08 | 2018-02-22 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 280029654 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT |
| 280009023 | 280006241 | 1.69 | 81 | Adjuvant (A) | 2016-07-19 | 2016-07-22 | Cisplatin + Doxorubicin | 2 | N | 280029662 | BCG |
| 280009024 | 280006242 | 1.75 | 85.8 | Palliative (P) | 2013-10-16 | 2013-11-25 | Doxorubicin + Gemcitabine | N | N | 280029663 | BCG |
| 280009025 | 280006242 | 1.56 | 51 | null | 2017-12-07 | 2018-01-05 | EURAMOS TRIAL | N | N | 280029663 | RITUXIMAB |
| 280009026 | 280006243 | 1.65 | 61.1 | Palliative (P) | 2014-09-14 | 2014-09-19 | PEMBROLIZUMAB | N | N | 280029668 | CVD |
| 280009027 | 280006244 | null | null | Palliative (P) | 2016-11-01 | 2016-11-08 | Panitumumab | 2 | N | 280029679 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280009028 | 280006245 | 1.77 | 53 | Palliative (P) | 2014-03-30 | 2015-02-08 | Capecitabine | Y | null | 280029681 | VIDE |
| 280009029 | 280006245 | 1.72 | null | Palliative (P) | null | 2017-07-21 | BCG Intravesical | N | N | 280029681 | CARBO + FLUOROURACIL |
| 280009030 | 280006246 | 1.72 | 61.1 | Palliative (P) | 2013-09-28 | 2013-11-14 | LIPOSOMAL DOXORUBICIN | null | null | 280029686 | VIDE |
| 280009031 | 280006248 | null | 65.5 | Palliative (P) | 2016-06-05 | 2016-06-06 | FLUOROURACIL + MITOMYCIN | N | N | 280029690 | CARBOPLATIN + LIPOSOMAL DOX |
| 280009032 | 280006249 | 1.77 | 77 | Palliative (P) | 2016-12-15 | 2016-12-15 | Pertuzumab + Trastuzumab IV | N | N | 280029691 | CARBO + FLUOROURACIL |
| 280009033 | 280006253 | 1.67 | 71.8 | Palliative (P) | 2018-04-07 | 2018-04-17 | Carboplatin + Liposomal Doxorubicin | N | N | 280029694 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009034 | 280006255 | null | 92.7 | Curative (C) | 2019-03-23 | 2019-05-20 | IVADo | 2 | N | 280029696 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009035 | 280006256 | null | 61.1 | Curative (C) | null | 2017-02-21 | Enzalutamide | N | N | 280029704 | NIVOLUMAB |
| 280009036 | 280006257 | 1.81 | 76.4 | Curative (C) | 2017-12-04 | 2017-12-09 | Cyclophosphamide + Topotecan | N | Y | 280029707 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280009037 | 280006260 | 1.62 | null | Palliative (P) | 2017-10-24 | 2017-10-24 | IVADo | null | Y | 280029708 | VIDE |
| 280009038 | 280006260 | 0 | null | Curative (C) | 2016-03-01 | 2016-03-01 | Carbo F | null | N | 280029708 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009039 | 280006261 | 1.47 | null | Curative (C) | 2017-03-11 | 2017-08-19 | DACTINOMYCIN + CYCLO + VINCRISTINE | N | N | 280029713 | EURAMOS TRIAL |
| 280009040 | 280006262 | 1.68 | 89.2 | Neo-adjuvant (N) | 2013-09-27 | 2013-11-18 | ECX | N | N | 280029715 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280009041 | 280006264 | 1.77 | null | Palliative (P) | 2014-04-14 | 2014-04-26 | CARBOPLATIN + FLUOROURACIL | N | N | 280029718 | PACLITAXEL + TRASTUZUMAB |
| 280009042 | 280006265 | 1.86 | null | Curative (C) | 2018-08-11 | 2018-08-14 | VINCRISTINE | N | N | 280029724 | VINCRISTINE |
| 280009043 | 280006265 | 0 | 56.6 | Palliative (P) | 2014-05-25 | 2014-06-19 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 280029724 | ETOPOSIDE |
| 280009044 | 280010725 | null | null | Neo-adjuvant (N) | 2016-04-29 | 2016-05-20 | Cyclophosphamide + Topotecan | 02 | N | 280029727 | BCG |
| 280009045 | 280011943 | 1.73 | 66.9 | Curative (C) | 2016-05-08 | 2016-06-05 | IMATINIB | N | N | 280029733 | VIDE |
| 280009046 | 280009279 | 1.83 | 76.5 | Curative (C) | 2015-03-31 | 2015-04-21 | IPILIMUMAB + NIVOLUMAB | 02 | N | 280029740 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280009047 | 280010726 | 1.78 | 88 | Palliative (P) | 2014-08-21 | 2014-08-28 | CAPECITABINE + CARBOPLATIN | 02 | N | 280029742 | METHOTREXATE + VINBLASTINE |
| 280009048 | 280006269 | 1.75 | 82.95 | Palliative (P) | 2015-06-15 | 2015-06-30 | EOX | 02 | N | 280029750 | CISPLATIN + ETOPOSIDE |
| 280009049 | 280006270 | 1.76 | 88 | Palliative (P) | 2017-04-29 | 2017-05-02 | CARBOPLATIN + GEMCITABINE | N | N | 280029753 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280009050 | 280006271 | null | null | Curative (C) | 2017-05-09 | 2017-06-05 | EOX | Y | N | 280029754 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280009051 | 280006271 | null | 55.3 | Palliative (P) | 2014-01-28 | 2014-01-28 | Cisplatin + Vinorelbine (PO) | 2 | N | 280029754 | CASPS TRIAL |
| 280009052 | 280006271 | 1.89 | null | Palliative (P) | 2015-03-18 | 2015-03-19 | Capecitabine + Streptozocin | N | Y | 280029754 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280009053 | 280006272 | 1.54 | 69.7 | Palliative (P) | 2015-08-01 | 2015-08-02 | IFOSFAMIDE + VINCRISTINE | 02 | null | 280029773 | NIVOLUMAB |
| 280009054 | 280006275 | 1.52 | 67.4 | Palliative (P) | 2014-07-10 | 2014-08-05 | FEC | 02 | Y | 280029775 | EURAMOS TRIAL |
| 280009055 | 280006275 | 1.8 | 49 | Palliative (P) | 2018-01-26 | 2018-02-09 | IPM | 2 | N | 280029775 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009056 | 280011771 | 1.56 | 69.1 | Disease modification (D) | 2019-03-09 | 2019-03-11 | Capecitabine (21days) + Carboplatin | N | N | 280029781 | LIPOSOMAL DOXORUBICIN |
| 280009057 | 280006280 | 1.52 | 66.3 | Curative (C) | 2016-06-25 | 2016-07-24 | OCTREOTIDE | Y | N | 280029782 | RITUXIMAB |
| 280009058 | 280006285 | 1.66 | 59 | Curative (C) | 2015-09-27 | 2015-09-27 | Cyclophosphamide + Vincristine | N | N | 280029783 | LIPOSOMAL DOXORUBICIN |